
Novartis PREVENT data show Cosentyx® helps patients realize early and lasting relief in axial spondyloarthritis
• Phase III PREVENT data show Cosentyx® 150 mg provided significant and sustained improvement in signs and symptoms of non-radiographic axial spondyloarthritis (nr-axSpA) up to […]